| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.038 | 0.5 |